MARKET

QLGN

QLGN

Qualigen Therapeutics Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.56
-0.22
-3.81%
After Hours: 5.51 -0.05 -0.90% 19:54 08/07 EDT
OPEN
5.65
PREV CLOSE
5.78
HIGH
5.75
LOW
5.33
VOLUME
2.05M
TURNOVER
--
52 WEEK HIGH
30.75
52 WEEK LOW
3.710
MARKET CAP
93.57M
P/E (TTM)
-0.3557
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average QLGN stock price target is 7.00 with a high estimate of 7.00 and a low estimate of 7.00.

EPS

QLGN News

More
Qualigen Therapeutics to Host Business Update Conference Call on August 18, 2020
PR Newswire · 2d ago
Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PR Newswire · 4d ago
Qualigen Therapeutics shares are trading lower after the company announced a $10 million registered direct offering.
Benzinga · 6d ago
Qualigen Therapeutics launches $10M direct offering
Qualigen Therapeutics (NASDAQ:QLGN) inks agreement with an institutional investor for the purchase and sale for $10M of (i) 1,717,106 common shares and (ii
seekingalpha · 6d ago
Qualigen Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PR Newswire · 6d ago
Qualigen ships its COVID-19 antibody test
Seeking Alpha · 07/30 14:28
Qualigen Therapeutics Begins Shipping FastPack® COVID-19 Antibody Test
PR Newswire · 07/30 13:00
QCOM, UPS among premarket gainers
Seeking Alpha · 07/30 12:24

Industry

Biotechnology & Medical Research
-0.18%
Pharmaceuticals & Medical Research
+0.08%

Hot Stocks

Symbol
Price
%Change

About QLGN

Qualigen Therapeutics, Inc., formerly Ritter Pharmaceuticals, Inc., is a biotechnology company. The Company is focused on the development and commercialization of therapeutic products for the treatment of cancer and infectious diseases, as well as development of its FastPack diagnostic platform. Its pipeline includes AS1411, Aptamer Linked Anti Nucleolin (ALAN), Aptamer Linked Anti Nucleolin - Contrast Enhancement (ALAN-CE), Aptamer Linked Anti Nucleolin - Radiation Enhancement (ALAN-RE), Selective Target Antigen Removal System (STARS) and RAS-F. The FastPack System is an immunoassay testing system, which consists of the FastPack Analyzer and the FastPack test pouch, a single-use, disposable, foil packet which includes the FastPack reagent chemistry. The Company’s subsidiary is Qualigen, Inc.
More

Webull offers kinds of Qualigen Therapeutics Inc stock information, including NASDAQ:QLGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QLGN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QLGN stock methods without spending real money on the virtual paper trading platform.